First Amendment to Amended and Restated Employment Agreement between Acceleron Pharma Inc. and Kevin F. McLaughlin

Contract Categories: Human Resources › Employment Agreements
Summary

This amendment updates the employment agreement between Acceleron Pharma Inc. and Kevin F. McLaughlin, the company's Senior Vice President and Chief Financial Officer. The main change is to replace references to "the second anniversary of the Amendment Date" in two sections of the original agreement with the specific date of September 9, 2015. All other terms of the original agreement remain unchanged.

Read More Arrow
EX-10.2 3 xlrn-2015911form8xkex102.htm EXHIBIT 10.2 Exhibit
Exhibit 10.2


FIRST AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT

This First Amendment (“First Amendment”), effective as of September 9, 2015, by and between Acceleron Pharma Inc., a Delaware corporation (“Acceleron”), and Kevin F. McLaughlin, Senior Vice President and Chief Financial Officer of Acceleron (the “Executive”), amends that certain Amended and Restated Employment Agreement between Executive and Acceleron, dated as of January 31, 2014 (“Agreement”). Together Acceleron and Executive are the “Parties” and each is a “Party”.
WHEREAS, in accordance with Section 12 of the Agreement, the Parties desire to amend the Agreement.

NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree to amend the Agreement as follows:

1.
In the first sentence of each of Sections 5(d)(i) and 5(d)(ii) of the Agreement, the text “the second anniversary of the Amendment Date” in each Section is hereby deleted and replaced with the text “September 9, 2015”.

2.
All other terms and conditions set forth in the Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the Parties hereto by their duly authorized representatives have executed this First Amendment effective as of the date first above written.

ACCELERON PHARMA INC.

By:    /s/ John L. Knopf, Ph.D.        
John L. Knopf, Ph.D.
Chief Executive Officer and President

By:    /s/ Joseph Zakrzewski        
Joseph Zakrzewski
Compensation Committee Chair

ACCEPTED AND AGREED:

Signature:     /s/ Kevin F. McLaughlin        
Kevin F. McLaughlin

Date:        September 9, 2015